Physician

Joshua Peter Alpers, M.D.

According to 2025 Medicare claims, Joshua Alpers, M.D. (NPI: 1801926100) practices neurology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is CONTINUUM HEALTH AIC INC (NPI: 1053039545; TIN: 870863830) and primary practice location at 37421-4778. Alpers is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Alpers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 191 traditional Medicare patients, billed 14,678 HCPCS/CPT codes, and received $478,597 in Medicare payments. The top billing code was 95909 (Nerve conduction, 5-6 studies). Part D data shows 441 prescription claims across 69 beneficiaries totaling $2,472,973 in drug costs, led by Radicava Ors (Edaravone). DME data shows 116 claims. Open Payments data shows 244 records totaling $157,193. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $60,009 to $478,597. Similarly, Part D prescription costs have moved sharply higher in recent years, from $18,893 to $2,472,973. In contrast, DME billing represents a smaller volume and declined steadily, from $123,210 to $51,571.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	248	1,485	$60,009
2016	202	2,109	$57,729
2017	256	2,342	$68,913
2018	325	1,707	$76,429
2019	312	953	$70,570
2020	269	1,591	$62,634
2021	188	1,449	$49,895
2022	190	1,968	$48,699
2023	196	4,064	$63,850
2024	191	14,678	$478,597

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	54	208	$18,893
2016	67	264	$28,495
2017	65	396	$408,735
2018	70	490	$457,487
2019	78	583	$846,388
2020	83	671	$1,929,219
2021	81	579	$2,594,608
2022	74	537	$4,224,370
2023	71	488	$3,160,907
2024	69	441	$2,472,973

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	37	$34,199
2016	N/R	183	$81,170
2017	14	95	$49,611
2018	32	225	$63,403
2019	19	186	$59,181
2020	12	117	$38,001
2021	11	115	$44,084
2022	11	267	$251,396
2023	N/R	101	$249,111
2024	N/R	116	$504,048

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95909	Nerve conduction, 5-6 studies	59	59	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	38	70	$87
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	71	74	$68
95885	Needle measurement of electrical activity in arm or leg muscles, limited study	52	61	$44
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	42	70	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Radicava Ors	Edaravone	49	1,372	$674,900
Evrysdi	Risdiplam	15	360	$393,979
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	36	812	$347,319
Mycophenolate Mofetil	Mycophenolate Mofetil	43	2,963	$14,697
Pyridostigmine Bromide	Pyridostigmine Bromide	79	5,868	$10,720

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	44	$487,152
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	14	$14,295
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	26	$2,187
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	32	$413

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	243	$148,993	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$8,200	Alexion Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joshua Peter Alpers, M.D.?

Tedicare shows public-source Medicare data for Joshua Peter Alpers, M.D. (NPI 1801926100), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Peter Alpers, M.D. have ACO affiliation data?

Joshua Peter Alpers, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Joshua Peter Alpers, M.D.?

Joshua Peter Alpers, M.D. is linked to CONTINUUM HEALTH AIC INC (billing NPI 1053039545) in the available physician profile data.

Does Joshua Peter Alpers, M.D. have Open Payments data?

Joshua Peter Alpers, M.D. has 244 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.